Patented pulsatile drug delivery technologies for chronotherapy

Bibliography

• Woods SC, Ramsay DS. Homeostasis: beyond Curt Richter. Appetite 2007;49:388-98
   PubMed Web of Science ®Google Scholar
• Bussemer T, Otto I, Bodmeier R. Pulsatile drug-delivery systems. Crit Rev Ther Drug Carrier Syst 2001;18:433-58
   PubMed Web of Science ®Google Scholar
• Medlicott NJ, Tucker IG. Pulsatile release from subcutaneous implants. Adv Drug Dev Rev 1999;38:139-49
   PubMed Web of Science ®Google Scholar
• Michael HS, Nicholas AP. Chronobiology, drug delivery, and chronotherapeutics. Adv Drug Dev Rev 2007;59:828-51
   Google Scholar
• Redfern P, Lemmer B. Physiology and pharmacology of biological rhythms, handbook of experimental pharmacology. Berlin: Springer; 1997
   Google Scholar
• Lemmer B. Chronobiology, drug-delivery, and chronotherapeutics. Adv Drug Dev Rev 2007;59:825-7
   PubMed Web of Science ®Google Scholar
• Medlicott NJ, Tucker IG. Pulsatile release from subcutaneous implants. Adv Drug Dev Rev 1999;38:139-49
   PubMed Web of Science ®Google Scholar
• Survase S, Kumar N. Pulsatile drug delivery: current scenario. CRIPS 2007;8:27-33
   Google Scholar
• Schellekens RCA, Stellaard F, Mitrovic D, et al. Pulsatile drug delivery to ileo-colonic segments by structured incorporation of disintegrants in pH-responsive polymer coatings. J Control Rel 2008;132:91-8
   PubMed Web of Science ®Google Scholar
• Peirce Management, LLC. Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent. US6500457; 2002
   Google Scholar
• Pharma Quest, Ltd. Pharmaceutical Dosage form for pulsatile delivery of methylphenidate. US65550136; 2003
   Google Scholar
• Eurand Pharmaceuticals Ltd. Timed pulsatile drug delivery systems. US6627223; 2003
   Google Scholar
• Dexcel Pharma Technologies. Immediate release gastrointestinal drug delivery system. US6531152; 2003
   Google Scholar
• Fujisawa Pharmaceutical Corp. Time-controlled explosion systems and processes for preparing the same. US4871549; 1989
   Google Scholar
• Andrx Pharmaceuticals, Inc. Pulsatile particles drug delivery system. US5472708; 1995
   Google Scholar
• Eurand Pharmaceuticals Ltd. Pulsatile release histamine H2 antagonist dosage form. US6663888; 2003
   Google Scholar
• BioAdvances LLC. Pulsatile drug delivery system. US5840329; 1998
   Google Scholar
• Krogel I, Bodmeier R. Pulsatile release from an insoluble capsule body controlled by an erodible plug. Pharm Res 1998;15:474-80
   PubMed Web of Science ®Google Scholar
• Ross A. Chronopharmaceutical drug delivery from a pulsatile capsule device based on programmable erosion. J Pharm Pharmacol 2000;52:903-9
   PubMed Web of Science ®Google Scholar
• Ueda S, Hata T, Asakura S. Development of a novel drug release system, time-controlled explosion system (TES). I. Concept and design. J Drug Target 1994;2:35-44
   PubMed Web of Science ®Google Scholar
• TSRL Inc. Multi stage drug delivery system. US 5387421; 1995
   Google Scholar
• Wockhardt Ltd. Process for the pulsatile delivery of diltiazem HCL and product produced thereby. US5914134; 1999
   Google Scholar
• Andrx Pharmaceuticals Inc. Multiparticulate pulsatile drug delivery system. EP 0701437; 2002
   Google Scholar
• Alza Corp. Osmotically driven delivery device with expandable orifice for pulsatile delivery effect. US5221278; 1993
   Google Scholar
• Alza Corp. Osmotically driven delivery devices with pulsatile effect. US5209746; 1993
   Google Scholar
• Morita R, Honda R, Takahashi Y. Development of oral controlled release preparations, a PVA swelling controlled release system (SCRS): I. Design of SCRS and its release controlling factor. J Control Release 2000;63:297-304
   PubMed Web of Science ®Google Scholar
• Krogel I, Bodmeier R. Floating or pulsatile drug delivery systems based on coated effervescent cores. Int J Pharm 1999;187:175-84
   PubMed Web of Science ®Google Scholar
• Bussemer T, Peppas N, Bodmeier R. Evaluation of the swelling, hydration and rupturing properties of the swelling layer of a rupturable pulsatile drug delivery system. Eur J Pharm Biopharm 2003;56:261-70
   PubMed Web of Science ®Google Scholar
• Fan TY, Wei SL, Yan WW, et al. An investigation of pulsatile release tablets with ethylcellulose and Eudragit® L as film coating materials and cross-linked polyvinylpyrrolidone in the core tablets. J Control Release 2001;77:245-51
   PubMed Web of Science ®Google Scholar
• Dashevsky A, Mohamad A. Development of pulsatile multiparticulate drug delivery system coated with aqueous dispersion Aquacoat® ECD. Int J Pharm 2006;318:124-31
   PubMed Web of Science ®Google Scholar
• Gazzaniga A, Sangalli M, Giordano F. Oral Chronotopic® drug delivery systems: achievement of time and/or site specificity. Eur J Pharm Biopharm 1994;40:246-50
   Web of Science ®Google Scholar
• Gazzaniga A, Busetti C, Moro L, et al. Time dependent oral delivery systems for colon targeting. S.T.P. Pharma Sci 1995;5:83-8
   Web of Science ®Google Scholar
• Gazzaniga A, Palugan L, Foppoli A, et al. Oral pulsatile delivery systems based on swellable hydrophilic polymers. Eur J Pharm Biopharm 2008;68:11-18
   PubMedGoogle Scholar
• Pharmidea Corp. Tablet for pharmaceutical use able to release active substances at successive times. US4865849; 1989
   Google Scholar
• University of Michigan. Pulsatile drug delivery system. US5229131; 1993
   Google Scholar
• Anda SR Pharmaceuticals, Inc. Pulsatile particles drug delivery system. US5260069; 1993
   Google Scholar
• Glaxo Group Ltd. Pharmaceutical compositions. US4897270; 1990
   Google Scholar
• Jagotec AG. Pharmaceutical tablet suitable to deliver the active substance in subsequent and predeterminable times. US6294200; 2001
   Google Scholar
• Dexcel Pharma Technologies Ltd. Delayed total release two pulse gastrointestinal drug delivery system. US6632451; 2003
   Google Scholar
• Impax Pharmaceuticals, Inc. Press coated pulsatile drug delivery system suitable for oral administration. US6372254; 2002
   Google Scholar
• Alza Corp. Multi-unit delivery system. US5110597; 1992
   Google Scholar
• Schering Corp. Controlled release flutamide composition. US5162117; 1992
   Google Scholar
• Alza Corp. Delivery devices with pulsatile effect. EP0627231; 1994
   Google Scholar
• Vyteris, Inc. Pulsatile delivery of Gonadotropin-releasing hormone from a pre-loaded integrated electrotransport patch. US0078373; 2007
   Google Scholar
• Drug Delivery Systems, Inc. Pulsating transdermal drug delivery system. US5013293; 1991
   Google Scholar
• Cygnus Therapeutic Systems. Device for administering drug transdermally which provides an initial pulse of drug. US5352456; 1994
   Google Scholar
• Dan Sibalis. Pulsating transdermal drug delivery system. US5312325; 1994
   Google Scholar
• Alza Corporation. Medical device for pulsatile transdermal delivery of biologically active agents. US4698062; 1987
   Google Scholar
• University of Utah. Pulsatile drug delivery device using stimuli sensitive hydrogel. US 5226902; 1993
   Google Scholar
• Coughlan DC, Quilty FP, Corrigan OI. Effect of drug physicochemical properties on swelling/deswelling kinetics and pulsatile drug release from thermoresponsive poly(N-isopropylacrylamide) hydrogels. J Control Release 2004;98:97-114
   PubMed Web of Science ®Google Scholar
• Kowanko IC, Pownall R, Knapp MS, et al. Circadian variations in the signs and symptoms of rheumatoid arthritis and in the therapeutic effectiveness of flurbiprofen at different times of the day. Br J Clin Pharmacol 1981;11:477-84
   PubMed Web of Science ®Google Scholar
• Patil S, Pund S, Joshi A, et al. Chronomodulated press-coated pulsatile therapeutic system for aceclofenac: optimization of factors influencing drug release and lag time. Chronophysiol Ther 2011;1:1-10
   Google Scholar
• Alza Corp. Composition comprising salbutamol. US 4751071; 1988
   Google Scholar
• Hongfei LIU, Tianhui SUN, Feiqian YU, et al. The Investigation of the pharmacokinetics of pulsatile-release salbutamol sulfate with pH-Sensitive ion exchange resin as the carriers in beagle dogs. Chem Pharm Bull 2007;55:480-1
   Google Scholar
• Smolensky MH, Lemmer B, Reinberg AE. Chronobiology and chronotherapy of allergic rhinitis and bronchial asthma. Adv Drug Dev Rev 2007;59:852-82
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Lemmer B, Portaluppi F, et al. Chronobiology and chronotherapy of ischemic heart disease. Adv Drug Dev Rev 2007;59:952-65
   PubMed Web of Science ®Google Scholar
• Smolensky MH, Portaluppi F. Chronopharmacology and chronotherapy of cardiovascular medications: relevance to prevention and treatment of coronary heart disease. Am Heart J 1999;137:14-24
   PubMed Web of Science ®Google Scholar
• Karavas E, Georgarakis E, Bikiaris D. Application of PVP/HPMC miscible blends with enhanced mucoadhesive properties for adjusting drug release in predictable pulsatile chronotherapeutics. Eur J Pharm Biopharm 2006;64:115-26
   PubMed Web of Science ®Google Scholar
• Muller JE, Stone PH, Turin ZG. The Millis Study Group: circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 1985;313:1315-22
   PubMed Web of Science ®Google Scholar
• Yadav D, Survase S, Kumar N. Dual coating of swellable and rupturable polymers on Glipizide loaded MCC pellets for pulsatile delivery: formulation design and in vitro evaluation. Int J Pharm 2011;419:121-30
   PubMed Web of Science ®Google Scholar
• Eriguchi M, Levi F, Hisa T, et al. Chronotherapy for cancer. Biomed Pharmacother 2003;57:92-5
   Web of Science ®Google Scholar
• Smolensky M, Campos LT. Marker rhythms for chronotherapy of cancer. Cancer Chemother Pharmacol 1994;34:270-2
   Google Scholar
• Adler S, Lung S, Langenmayer I, et al. Chronotherapy with 5-Fluorouracil and folinic acid in advanced colorectal carcinoma. Cancer 1994;73:2905-12
   PubMedGoogle Scholar
• Solomon GD. Circadian rhythms and migraine. Clevel Clin J Med 1992;59:326-9
   PubMed Web of Science ®Google Scholar
• Fox AW, Davis RL. Migraine chronobiology. Headache 1998;38:436-341
   PubMed Web of Science ®Google Scholar
• Hofstra WA, Palen JV, Weerd AW. Morningness and eveningness: when do patients take their antiepileptic drugs? Epilepsy Behav 2012;23:320-3
   PubMed Web of Science ®Google Scholar
• Guilhoto LM, Loddenkemper T, Vendrame M, et al. Higher evening antiepileptic drug dose for nocturnal and early-morning seizures. Epilepsy Behav 2011;20:334-7
   Web of Science ®Google Scholar
• Graf W, Fraunberger B, Yang T, et al. Once daily monotherapy with prolonged-release valproate minitablets given in the evening--a chronopharmacological study. Int J Clin Pharmacol Ther 2009;47:439-43
   Google Scholar